Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Michael A. Lahart"'
Autor:
Edon J. Rabinowitz, Blaire Kulp, Michael A. Lahart, Jennifer N. Avari Silva, Dilip S. Nath, Patrick A. Dillon, Ahmed S. Said
Publikováno v:
ASAIO journal (American Society for Artificial Internal Organs : 1992). 69(1)
Autor:
Michael A. Lahart, Emily L. Burns, Madison M. Streb, Hongjie Gu, Tara M. Neumayr, Aaron M. Abarbanell, Ahmed S. Said
Publikováno v:
ASAIO journal (American Society for Artificial Internal Organs : 1992). 68(11)
There is an increasing interest in the use of bivalirudin for pediatric extracorporeal membrane oxygenation (ECMO) anticoagulation. However, dosing is not well described in those requiring continuous renal replacement therapy (CRRT). We aimed to dete
Autor:
Michael A. Lahart, Ahmed S. Said, Emily L. Burns, Matthew T. Douds, Aaron M. Abarbanell, Matthew R. Schill
Publikováno v:
Artificial Organs. 45:15-21
There is a paucity of data regarding the use of direct thrombin inhibitors such as bivalirudin for children on extracorporeal life support (ECLS). We sought to compare the outcomes of children on ECLS anticoagulated with bivalirudin versus heparin. P
Autor:
Jose A Pineda, Christopher McPherson, Kara S Kniska, Michael A. Lahart, Meghan J Kolf, Caitlyn M Luecke
Publikováno v:
The Journal of Pediatric Pharmacology and Therapeutics. 25:241-245
OBJECTIVE Although levetiracetam is used for the prevention of early Post-traumatic seizures (EPTS) after traumatic brain injury (TBI), limited data exist describing the incidence of seizures in pediatric patients receiving levetiracetam prophylaxis.
Publikováno v:
Journal of Pediatric Intensive Care.
Objectives Methylnaltrexone is U.S. Food and Drug Administration (FDA) approved as a subcutaneous injection for adults with opioid-induced constipation (OIC). Case series have described the use of methylnaltrexone for OIC in the pediatric oncology po
Publikováno v:
ASAIO Journal.
Anticoagulation in extracorporeal membrane oxygenation (ECMO) is challenging, with significant morbidity and mortality associated with thrombotic complications. Unfractionated heparin (UFH) is commonly used, which depends on native antithrombin (AT)
Autor:
Shelley D. Miyamoto, Jane Gralla, Melanie D. Everitt, Michael A. Lahart, Jennifer Eshelman, Ann Heble
Publikováno v:
Pediatric Transplantation. 22:e13093
mTOR inhibitors have been associated with SWC when used in the perioperative period. Limited literature is available to guide providers in managing chronic mTOR inhibitor use in the perioperative period, especially in the pediatric setting. The prima